S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
NYSE:KBH

KB Home (KBH) Competitors

$48.74
+0.55 (+1.14%)
(As of 06/9/2023 ET)
Compare
Today's Range
$48.15
$49.18
50-Day Range
$38.40
$48.74
52-Week Range
$24.78
$49.48
Volume
1.36 million shs
Average Volume
1.25 million shs
Market Capitalization
$4.02 billion
P/E Ratio
5.36
Dividend Yield
1.23%
Price Target
$42.27

KBH vs. MTH, TPH, MDC, MHO, TOL, TMHC, CCS, DFH, SUM, and AZEK

Should you be buying KB Home stock or one of its competitors? The main competitors of KB Home include Meritage Homes (MTH), Tri Pointe Homes (TPH), M.D.C. (MDC), M/I Homes (MHO), Toll Brothers (TOL), Taylor Morrison Home (TMHC), Century Communities (CCS), Dream Finders Homes (DFH), Summit Materials (SUM), and AZEK (AZEK). These companies are all part of the "construction" sector.

KB Home vs.

KB Home (NYSE:KBH) and Meritage Homes (NYSE:MTH) are both mid-cap construction companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

KB Home currently has a consensus target price of $42.27, suggesting a potential downside of 13.28%. Meritage Homes has a consensus target price of $115.14, suggesting a potential downside of 11.20%. Given Meritage Homes' stronger consensus rating and higher possible upside, analysts plainly believe Meritage Homes is more favorable than KB Home.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KB Home
0 Sell rating(s)
8 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.43
Meritage Homes
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56

Meritage Homes has lower revenue, but higher earnings than KB Home. Meritage Homes is trading at a lower price-to-earnings ratio than KB Home, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KB Home$6.90 billion0.58$816.67 million$9.105.36
Meritage Homes$6.27 billion0.76$992.19 million$24.505.29

In the previous week, Meritage Homes had 5 more articles in the media than KB Home. MarketBeat recorded 15 mentions for Meritage Homes and 10 mentions for KB Home. Meritage Homes' average media sentiment score of 0.73 beat KB Home's score of 0.44 indicating that Meritage Homes is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KB Home
2 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Meritage Homes
6 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Meritage Homes has a net margin of 14.44% compared to KB Home's net margin of 11.73%. Meritage Homes' return on equity of 23.99% beat KB Home's return on equity.

Company Net Margins Return on Equity Return on Assets
KB Home 11.73% 22.86% 12.21%
Meritage Homes 14.44% 23.99% 16.09%

KB Home received 109 more outperform votes than Meritage Homes when rated by MarketBeat users. However, 56.24% of users gave Meritage Homes an outperform vote while only 48.09% of users gave KB Home an outperform vote.

CompanyUnderperformOutperform
KB HomeOutperform Votes
528
48.09%
Underperform Votes
570
51.91%
Meritage HomesOutperform Votes
419
56.24%
Underperform Votes
326
43.76%

KB Home has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Meritage Homes has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500.

89.3% of KB Home shares are owned by institutional investors. Comparatively, 95.6% of Meritage Homes shares are owned by institutional investors. 4.4% of KB Home shares are owned by insiders. Comparatively, 2.0% of Meritage Homes shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

KB Home pays an annual dividend of $0.60 per share and has a dividend yield of 1.2%. Meritage Homes pays an annual dividend of $1.08 per share and has a dividend yield of 0.8%. KB Home pays out 6.6% of its earnings in the form of a dividend. Meritage Homes pays out 4.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Meritage Homes beats KB Home on 13 of the 19 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KBH vs. The Competition

MetricKB HomeOperative builders IndustryConstruction SectorNYSE Exchange
Market Cap$4.02B$5.93B$6.30B$14.99B
Dividend Yield1.25%1.05%2.65%3.85%
P/E Ratio5.365.4912.8019.31
Price / Sales0.580.749.989.28
Price / Cash4.836.0714.6324.62
Price / Book1.141.633.087.33
Net Income$816.67M$962.84M$554.33M$900.99M
7 Day Performance6.70%3.93%1.69%1.75%
1 Month Performance7.26%4.77%3.50%3.87%
1 Year Performance56.22%61.76%11.60%-2.53%

KB Home Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MTH
Meritage Homes
2.0081 of 5 stars
$128.75
+5.7%
$115.14
-10.6%
+54.8%$4.71B$6.27B5.261,773Analyst Revision
News Coverage
TPH
Tri Pointe Homes
2.3572 of 5 stars
$32.45
+5.0%
$27.00
-16.8%
+56.8%$3.25B$4.30B5.911,470Positive News
MDC
M.D.C.
2.2913 of 5 stars
$43.74
+4.4%
$27.50
-37.1%
+19.5%$3.20B$5.50B6.501,643
MHO
M/I Homes
2.2446 of 5 stars
$75.31
+3.7%
$73.00
-3.1%
+67.3%$2.10B$4.27B4.241,663
TOL
Toll Brothers
2.334 of 5 stars
$74.05
+4.5%
$65.85
-11.1%
+50.2%$8.20B$10.28B5.915,200Analyst Upgrade
Analyst Revision
TMHC
Taylor Morrison Home
1.6744 of 5 stars
$46.28
+4.6%
$40.79
-11.9%
+69.0%$5.05B$8.22B4.913,000Insider Selling
News Coverage
High Trading Volume
CCS
Century Communities
2.0724 of 5 stars
$70.31
+4.4%
$56.50
-19.6%
+34.2%$2.25B$4.51B5.521,537Insider Selling
News Coverage
Positive News
DFH
Dream Finders Homes
1.627 of 5 stars
$20.90
+7.6%
$10.00
-52.2%
+43.7%$1.95B$3.34B8.461,170News Coverage
Positive News
SUM
Summit Materials
1.5675 of 5 stars
$33.92
+2.3%
$34.08
+0.5%
+26.3%$4.03B$2.41B14.874,800News Coverage
Positive News
AZEK
AZEK
1.6252 of 5 stars
$26.82
+4.4%
$28.17
+5.0%
+18.8%$4.05B$1.36B298.002,182Insider Selling
Gap Down

Related Companies and Tools

This page (NYSE:KBH) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -